TY  - JOUR
AU  - Global Retinoblastoma Study Group
PY  - 2022
DO  - 10.1016/S2214-109X(22)00250-9
UR  - http://hdl.handle.net/10668/22557
T2  - The Lancet. Global health
AB  - Retinoblastoma is the most common intraocular cancer worldwide. There is some evidence to suggest that major differences exist in treatment outcomes for children with retinoblastoma from different regions, but these differences have not been assessed...
LA  - en
KW  - Child
KW  - Eye Enucleation
KW  - Humans
KW  - Infant
KW  - Prospective Studies
KW  - Retinal Neoplasms
KW  - Retinoblastoma
KW  - Treatment Outcome
TI  - The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries.
TY  - research article
VL  - 10
ER  -